Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glucagon Clearance in Type 2 Diabetes
NCT02475421Completed
- Sponsor
- Gentofte Hospital
- Start
- May 2015
- Primary completion
- Dec 2016
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label trial of glucagon in type 2 diabetes mellitus (T2DM) (4 arms), sponsored by Gentofte Hospital. Primary endpoint: Metabolic clearance rate of glucagon. Started May 2015; status: completed.
02
Drugs
glucagon
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02475421.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02475421.